THESEUS PHARMACEUTICALS INC's ticker is and the CUSIP is 88369M101. A total of 1 filers reported holding THESEUS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,273 | -72.1% | 1,216,500 | -3.1% | 0.00% | -100.0% |
| Q2 2023 | $11,720 | -0.4% | 1,256,009 | -5.2% | 0.00% | 0.0% |
| Q1 2023 | $11,772 | +79.9% | 1,325,565 | +0.9% | 0.00% | +100.0% |
| Q4 2022 | $6,543 | -99.9% | 1,313,908 | -4.9% | 0.00% | 0.0% |
| Q3 2022 | $8,013,000 | +4.6% | 1,381,489 | -0.3% | 0.00% | 0.0% |
| Q2 2022 | $7,661,000 | -53.0% | 1,385,283 | -3.6% | 0.00% | -50.0% |
| Q1 2022 | $16,312,000 | +0.7% | 1,436,616 | +10.6% | 0.00% | +100.0% |
| Q4 2021 | $16,201,000 | – | 1,299,487 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Opportunity Management V, LLC | 959,275 | $5,305,000 | 13.37% |
| Foresite Capital Management V, LLC | 3,335,346 | $18,444,000 | 12.88% |
| Lynx1 Capital Management LP | 504,862 | $2,792,000 | 2.38% |
| Orbimed Advisors | 17,041,668 | $94,240,000 | 1.71% |
| Omega Fund Management, LLC | 711,479 | $3,934,000 | 1.26% |
| Nextech Invest Ltd. | 611,310 | $3,381,000 | 1.14% |
| Boxer Capital, LLC | 892,057 | $4,933,000 | 0.31% |
| DAFNA Capital Management LLC | 81,899 | $453,000 | 0.12% |
| Opaleye Management Inc. | 32,300 | $179,000 | 0.08% |
| Rock Springs Capital Management LP | 437,329 | $2,418,000 | 0.07% |